Cargando…

Eritoran Attenuates Hepatic Inflammation and Fibrosis in Mice with Chronic Liver Injury

Toll-like receptor 4 (TLR4) signaling plays a key role in liver inflammation and fibrosis. The therapeutic effects of eritoran, a TLR4 antagonist, in mice with chronic liver injury remained unclear. C57BL/6 mice were fed a fast-food diet (FFD) or treated with carbon tetrachloride (CCl(4)) to induce...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hsieh, Yun-Cheng, Lee, Kuei-Chuan, Wu, Pei-Shan, Huo, Teh-Ia, Huang, Yi-Hsiang, Hou, Ming-Chih, Lin, Han-Chieh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8235164/ https://www.ncbi.nlm.nih.gov/pubmed/34205789 http://dx.doi.org/10.3390/cells10061562

Ejemplares similares

(Pro)renin Receptor Knockdown Attenuates Liver Fibrosis Through Inactivation of ERK/TGF-β1/SMAD3 Pathway
por: Hsieh, Yun-Cheng, et al.
Publicado: (2021)

Eritoran insight for influenza treatment
por: Baas, Tracey
Publicado: (2013)

Correlation and prognostic accuracy between noninvasive liver fibrosismarkers and portal pressure in cirrhosis: Role of ALBI score
por: Hsieh, Yun-Cheng, et al.
Publicado: (2018)

Eritoran: the evidence of its therapeutic potential in sepsis
por: Raja, Shahzad G., et al.
Publicado: (2007)

Aliskiren Attenuates Steatohepatitis and Increases Turnover of Hepatic Fat in Mice Fed with a Methionine and Choline Deficient Diet
por: Lee, Kuei-Chuan, et al.
Publicado: (2013)

CXCL9 Associated with Sustained Virological Response in Chronic Hepatitis B Patients Receiving Peginterferon Alfa-2a Therapy: A Pilot Study
por: Lee, I-Cheng, et al.
Publicado: (2013)

Mac-2 binding protein glycosylation isomer is a potential biomarker to predict portal hypertension and bacterial infection in cirrhotic patients
por: Wu, Pei-Shan, et al.
Publicado: (2021)

IL28B Polymorphism Correlates with Active Hepatitis in Patients with HBeAg-Negative Chronic Hepatitis B
por: Lee, I-Cheng, et al.
Publicado: (2013)

Predictors of response to pegylated interferon in chronic hepatitis B: a real-world hospital-based analysis
por: Wang, Yin-Chen, et al.
Publicado: (2016)

Effect of the Toll-Like Receptor 4 Antagonist Eritoran on Retinochoroidal Inflammatory Damage in a Rat Model of Endotoxin-Induced Inflammation
por: Ekici, Feyzahan, et al.
Publicado: (2014)

Current noninvasive liver reserve models do not predict histological fibrosis severity in hepatocellular carcinoma
por: Ho, Shu-Yein, et al.
Publicado: (2018)

0986. The effect of eritoran on the severity of lung injury in two different rat lung injury models
por: Kundakci, A, et al.
Publicado: (2014)

The Toll-Like Receptor 4 Antagonist Eritoran Protects Mice from Lethal Filovirus Challenge
por: Younan, Patrick, et al.
Publicado: (2017)

Pathogenesis and treatment of non-alcoholic steatohepatitis and its fibrosis
por: Lee, Kuei-Chuan, et al.
Publicado: (2023)

Evaluation of eritoran tetrasodium (E5564), a TLR4 antagonist, on the QTc interval in healthy subjects
por: Nagy, CF, et al.
Publicado: (2011)

Safety, pharmacokinetics, and pharmacodynamics of 4-hour intravenous infusion of eritoran tetrasodium in healthy Japanese and Caucasian males
por: Okubo, Y, et al.
Publicado: (2011)

Gastrointestinal and liver manifestations in patients with COVID-19
por: Lee, I-Cheng, et al.
Publicado: (2020)

Risk of recurrence in chronic hepatitis B patients developing hepatocellular carcinoma with antiviral secondary prevention failure
por: Lee, I-Cheng, et al.
Publicado: (2017)

Fatty Liver Index and Lipid Accumulation Product Can Predict Metabolic Syndrome in Subjects without Fatty Liver Disease
por: Cheng, Yuan-Lung, et al.
Publicado: (2017)

Influence of severity of illness on the effects of eritoran tetrasodium (E5564), a TLR4 antagonist, in patients with severe sepsis
por: Opal, SM, et al.
Publicado: (2009)

Aliskiren Reduces Hepatic steatosis and Epididymal Fat Mass and Increases Skeletal Muscle Insulin Sensitivity in High-Fat Diet-Fed Mice
por: Lee, Kuei-Chuan, et al.
Publicado: (2016)

Early echocardiographic signs of diastolic dysfunction predict acute kidney injury in cirrhotic patients
por: Wu, Pei-Shan, et al.
Publicado: (2020)

Survival of Patients with Hepatocellular Carcinoma in Renal Insufficiency: Prognostic Role of Albumin-Bilirubin Grade
por: Ho, Shu-Yein, et al.
Publicado: (2020)

Moderate exercise training attenuates aging-induced cardiac inflammation, hypertrophy and fibrosis injuries of rat hearts
por: Liao, Po-Hsiang, et al.
Publicado: (2015)

Prognostic role of noninvasive liver reserve markers in patients with hepatocellular carcinoma undergoing transarterial chemoembolization
por: Ho, Shu-Yein, et al.
Publicado: (2017)

Liver stiffness measured by acoustic radiation force impulse elastography predicted prognoses of hepatocellular carcinoma after radiofrequency ablation
por: Lee, Pei-Chang, et al.
Publicado: (2020)

A New Treatment-integrated Prognostic Nomogram of the Barcelona Clinic Liver Cancer System for Hepatocellular Carcinoma
por: Hsu, Chia-Yang, et al.
Publicado: (2017)

Phillygenin Attenuates Carbon Tetrachloride-Induced Liver Fibrosis via Modulating Inflammation and Gut Microbiota
por: Wang, Cheng, et al.
Publicado: (2021)

Synthesized HMGB1 peptide attenuates liver inflammation and suppresses fibrosis in mice
por: Nojiri, Shunsuke, et al.
Publicado: (2021)

Carvedilol Attenuates the Progression of Hepatic Fibrosis Induced by Bile Duct Ligation
por: Tian, Xiaopeng, et al.
Publicado: (2017)

Octreotide attenuates liver fibrosis by inhibiting hepatic heme oxygenase-1 expression
por: GUO, SHI-BIN, et al.
Publicado: (2015)

Prognostic Performance of Ten Liver Function Models in Patients with Hepatocellular Carcinoma Undergoing Radiofrequency Ablation
por: Ho, Shu-Yein, et al.
Publicado: (2018)

Quantification of liver fibrosis in chronic hepatitis B virus infection
por: Jieanu, CF, et al.
Publicado: (2015)

The impact of esophagogastric varices on the prognosis of patients with hepatocellular carcinoma
por: Hsieh, Wei-Yao, et al.
Publicado: (2017)

Comparison of Four Albumin-Based Liver Reserve Models (ALBI/EZ-ALBI/PALBI/PAL) against MELD for Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization
por: Ho, Shu-Yein, et al.
Publicado: (2023)

Hirsutella sinensis mycelium attenuates bleomycin-induced pulmonary inflammation and fibrosis in vivo
por: Huang, Tsung-Teng, et al.
Publicado: (2015)

Comparison of twelve liver functional reserve models for outcome prediction in patients with hepatocellular carcinoma undergoing surgical resection
por: Ho, Shu-Yein, et al.
Publicado: (2018)

Hong Kong Liver Cancer Staging System Is Associated With Better Performance for Hepatocellular Carcinoma: Special Emphasis on Viral Etiology
por: Liu, Po-Hong, et al.
Publicado: (2015)

Curcumin attenuates angiogenesis in liver fibrosis and inhibits angiogenic properties of hepatic stellate cells
por: Zhang, Feng, et al.
Publicado: (2014)

Carvedilol attenuates carbon tetrachloride-induced liver fibrosis and hepatic sinusoidal capillarization in mice
por: Wu, Ying, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_c0bcqfc99q5s9gbajbhee1q1eo